Genome Editing for the Study of Cardiovascular Diseases.
about
Advances in the delivery of RNA therapeutics: from concept to clinical reality.Treatment of Dyslipidemia Using CRISPR/Cas9 Genome Editing.Present Status and Future Challenges of New Therapeutic Targets in Preclinical Models of Stroke in Aged Animals with/without Comorbidities.New perspectives: systems medicine in cardiovascular disease.
P2860
Genome Editing for the Study of Cardiovascular Diseases.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Genome Editing for the Study of Cardiovascular Diseases.
@en
Genome Editing for the Study of Cardiovascular Diseases.
@nl
type
label
Genome Editing for the Study of Cardiovascular Diseases.
@en
Genome Editing for the Study of Cardiovascular Diseases.
@nl
prefLabel
Genome Editing for the Study of Cardiovascular Diseases.
@en
Genome Editing for the Study of Cardiovascular Diseases.
@nl
P2860
P1476
Genome Editing for the Study of Cardiovascular Diseases.
@en
P2093
Alexandra C Chadwick
Kiran Musunuru
P2860
P2888
P356
10.1007/S11886-017-0830-5
P577
2017-03-01T00:00:00Z